BeInCrypto·

A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year

Your call?
663%
Moderna 2026 gain

Moderna stock is up 663% in 2026, beating AI names for the S&P 500 lead. Full cancer vaccine data arrives October 24.

Share

More news